| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mazin Khalid, Oluwole Jegede, Vijay Gayam, Ying Chi Yang, Binav Shrestha, Amrendra Mandal, Osama Mukhtar, Pavani Garlapati, Mowyad Khalid, Alix Dufresn. Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review. Case reports in medicine. vol 2019. 2020-09-30. PMID:31049067. |
clozapine is an atypical antipsychotic agent indicated in the treatment of medication-resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Mazin Khalid, Oluwole Jegede, Vijay Gayam, Ying Chi Yang, Binav Shrestha, Amrendra Mandal, Osama Mukhtar, Pavani Garlapati, Mowyad Khalid, Alix Dufresn. Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review. Case reports in medicine. vol 2019. 2020-09-30. PMID:31049067. |
we present a 21-year-old patient who was started on clozapine for management of schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Yuji Otsuka, Keita Idemoto, Yutaka Hosoda, Yukitsugu Imamura, Tsutomu Aok. Clozapine-induced myocarditis: Follow-up for 3.5 years after successful retrial. Journal of general and family medicine. vol 20. issue 3. 2020-09-30. PMID:31065477. |
it may be possible to take clozapine for a long time even after clozapine-induced myocarditis, and thus improve the life expectancy of schizophrenia patients. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pradeep Kumar, Dheerendra Kumar Mishra, Nimisha Mishra, Sunil Ahuja, Gyanendra Raghuvanshi, Vijay Niranja. Acute onset clozapine-induced hyperglycaemia: A case report. General psychiatry. vol 32. issue 2. 2020-09-30. PMID:31179433. |
clozapine is reserved especially for resistant schizophrenia due to its side effects. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pradeep Kumar, Dheerendra Kumar Mishra, Nimisha Mishra, Sunil Ahuja, Gyanendra Raghuvanshi, Vijay Niranja. Acute onset clozapine-induced hyperglycaemia: A case report. General psychiatry. vol 32. issue 2. 2020-09-30. PMID:31179433. |
in this case, a patient with resistant schizophrenia was presented with acute-onset hyperglycaemia and delirium with the use of clozapine within a week. |
2020-09-30 |
2023-08-13 |
Not clear |
| Masashi Ito, Yasuto Kunii, Sho Horikoshi, Itaru Miura, Shuntaro Itagaki, Tetsuya Shiga, Hirooki Yab. Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report. International medical case reports journal. vol 12. 2020-09-30. PMID:31297000. |
young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report. |
2020-09-30 |
2023-08-13 |
Not clear |
| Asiel Yair Adan Sanchez, Jessica J Foster, Carla M Plymen, Sukhi Shergil. Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report - ADDENDUM. BJPsych open. vol 5. issue 4. 2020-09-30. PMID:31530298. |
clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report - addendum. |
2020-09-30 |
2023-08-13 |
Not clear |
| Gabriela D William. Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report. The mental health clinician. vol 9. issue 5. 2020-09-30. PMID:31534873. |
a 67-year-old african american male with a past medical history significant for hypertension, coronary artery disease requiring stent placement, mitral insufficiency, hyperlipidemia, tobacco use disorder, and schizophrenia presented with altered mental status and disorientation in the setting of clozapine nonadherence, which prompted acute hospitalization for clozapine reinitiation. |
2020-09-30 |
2023-08-13 |
Not clear |
| Kazım Cihan Can, Demet Karnak, Halise devrİmcİ Özgüve. A Very Rare Adverse Effect of Clozapine, Clozapine-induced Interstitial Lung Disease: Case Report and Literature Review. Noro psikiyatri arsivi. vol 56. issue 4. 2020-09-30. PMID:31903043. |
clozapine is the gold-standard antipsychotic agent for treatment-resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Iluminada Corripio, Alexandra Roldán, Salvador Sarró, Peter J McKenna, Anna Alonso-Solís, Mireia Rabella, Anna Díaz, Dolors Puigdemont, Víctor Pérez-Solà, Enric Álvarez, Antonio Arévalo, Pedro P Padilla, Jesus M Ruiz-Idiago, Rodrigo Rodríguez, Joan Molet, Edith Pomarol-Clotet, Maria J Portell. Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial. EBioMedicine. vol 51. 2020-09-30. PMID:31927311. |
up to 30% of patients with schizophrenia are resistant to antipsychotic drug treatment, with 60% of such cases also failing to respond to clozapine. |
2020-09-30 |
2023-08-13 |
Not clear |
| Jonathan G Leung, Jade L Kutzke, Robert J Morgan, Kathryn M Scha. Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea. The mental health clinician. vol 10. issue 1. 2020-09-30. PMID:31942277. |
clozapine is approved by the us food and drug administration for treatment-resistant schizophrenia and mitigation of suicidality in patients with schizophrenia or schizoaffective disorder. |
2020-09-30 |
2023-08-13 |
Not clear |
| Danielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, Steven G Potkin, Herbert Y Meltzer, Joanne Knight, Gary Remington, Daniel J Müller, James L Kenned. Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine. Molecular neuropsychiatry. vol 2. issue 4. 2020-09-29. PMID:28277565. |
altered glutamate neurotransmission is implicated in the etiology of schizophrenia (scz) and the pharmacogenetics of response to clozapine (clz), which is the drug of choice for treatment-resistant scz. |
2020-09-29 |
2023-08-13 |
Not clear |
| Quevedo-Florez Leonardo, Granada-Romero Juliana, Camargo-Arenas Juan Fernand. Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine. Case reports in emergency medicine. vol 2017. 2020-09-29. PMID:28303200. |
our case addresses a 55-year-old patient diagnosed with undifferentiated schizophrenia for 10 years, who had been receiving clozapine and clonazepam as part of their treatment. |
2020-09-29 |
2023-08-13 |
Not clear |
| Letícia S Czepielewski, Marina D B Londero, Mathias H de Sousa, Carolina P Perin, Helena C Maldonado, Felipe C A Claudino, Clarissa S Gam. Long-term treatment with clozapine and verbal memory performance in schizophrenia. Schizophrenia research. Cognition. vol 12. 2020-09-29. PMID:29928595. |
long-term treatment with clozapine and verbal memory performance in schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Letícia S Czepielewski, Marina D B Londero, Mathias H de Sousa, Carolina P Perin, Helena C Maldonado, Felipe C A Claudino, Clarissa S Gam. Long-term treatment with clozapine and verbal memory performance in schizophrenia. Schizophrenia research. Cognition. vol 12. 2020-09-29. PMID:29928595. |
although clozapine has a unique profile for reducing clinical symptoms, it may not have an additional benefit for cognition when started later on the course of schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Brent Curry, Emma Palmer, Crystal Mounce, Gilbert Smith, Vital Sha. Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy. The mental health clinician. vol 8. issue 2. 2020-09-29. PMID:29955547. |
clozapine is an atypical antipsychotic medication approved for treatment-resistant schizophrenia and suicidal behavior in schizophrenia or schizoaffective disorders. |
2020-09-29 |
2023-08-13 |
Not clear |
| Shamir N Kalaria, Deanna L Kell. Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes. Neuropsychiatric disease and treatment. vol 15. 2020-09-29. PMID:31692521. |
although clozapine has demonstrated superior efficacy in patients with schizophrenia and other serious mental health illness, drug utilization rates are significantly low due to safety concerns and administration challenges. |
2020-09-29 |
2023-08-13 |
Not clear |
| Arpit Parmar, Rajeev Ranjan, Rajesh Saga. Successful Management of Patient with Treatment Resistant Schizophrenia and Swyer-James-Macleod Syndrome with Clozapine. Indian journal of psychological medicine. vol 38. issue 5. 2020-09-28. PMID:27833234. |
successful management of patient with treatment resistant schizophrenia and swyer-james-macleod syndrome with clozapine. |
2020-09-28 |
2023-08-13 |
Not clear |
| Arpit Parmar, Rajeev Ranjan, Rajesh Saga. Successful Management of Patient with Treatment Resistant Schizophrenia and Swyer-James-Macleod Syndrome with Clozapine. Indian journal of psychological medicine. vol 38. issue 5. 2020-09-28. PMID:27833234. |
we report a very unusual case of sjms along with comorbid schizophrenia in a 20-year-old female and the successful management using clozapine. |
2020-09-28 |
2023-08-13 |
Not clear |
| Vijaya Kumar, Virupakshappa Bagewadi, Dayanand Sagar, Shivarama Varamball. Multimodal Hallucinations in Schizophrenia and Its Management. Indian journal of psychological medicine. vol 39. issue 1. 2020-09-28. PMID:28250565. |
here, we report mmh in two patients of treatment-resistant schizophrenia and its successful management with clozapine. |
2020-09-28 |
2023-08-13 |
Not clear |